By Peet Serfontein & Pritu Makan
We initiate a long position. Our upside target is set at R16. We recommend a stop-loss at R13.40.
Netcare operates the largest private hospital network in South Africa. The group also offers primary healthcare, sub-acute care, day surgery, occupational health and employee wellness services through Medicross, emergency medical services through Netcare 911, renal dialysis through National Renal Care and mental health and psychiatric services through Akeso. Netcare is also a leading private trainer of emergency medical and nursing personnel in the country.
The group boasts a market-leading position in South Africa with a defensive portfolio that has been augmented by the addition of mental health facilities as well - a noteworthy competitive advantage. Thematically, we like the hospital space in South Africa with a rising middle class likely to support long-term growth in demand for quality healthcare.
Technically, a double-bottom pattern in the share price makes for an appealing long position (see insert on main chart). The pattern reflects a shift in market sentiment, where selling pressure weakens, and buyers begin to re-enter at a perceived value area.
The start of upside momentum, according to the Moving Average Convergence Divergence (MACD) histogram indicator, supports the trade idea. When the MACD histogram shifts from negative to positive territory or begins to print higher bars while still below the zero line, it suggests that the rate of decline is slowing and that a potential bullish crossover may be forming. This early signal of strengthening momentum often precedes an actual price breakout, giving investors a lead indication of a possible reversal or continuation to the upside.
The price is in the accumulation phase of the Wyckoff Price Cycle, further supporting a bullish tone.
We suggest a medium capital at-risk allocation to this trade. Increase exposure for a break above R14.50.
Share Information | |
---|---|
Share Code | NTC |
Industry | Health Care Equipment & Services |
Market Capital (ZAR) | 19.57 billion |
One Year Total Return | 29.19% |
Return Year-to-Date | -1.25% |
Current Price (ZAR) | 14.34 |
52 Week High (ZAR) | 15.77 |
52 Week Low (ZAR) | 11.02 |
Financial Year End | September |
While the share has sold off heavily since the start of the year, a recovery can continue with several technical indicators supporting further upside momentum. The share is also testing its 200-day simple moving average. |
Consensus Expectations (Bloomberg) | ||||
---|---|---|---|---|
FY24 | FY25E | FY26E | FY27E | |
Headline Earnings per Share (ZAR) | 1.12 | 1.32 | 1.51 | 1.68 |
Growth (%) | 17.95 | 14.16 | 11.41 | |
Dividend Per Share (ZAR) | 0.70 | 0.84 | 0.95 | 1.08 |
Growth (%) | 20.14 | 13.32 | 13.43 | |
Forward PE (times) | 10.86 | 9.51 | 8.54 | |
Forward Dividend Yield (%) | 5.86 | 6.65 | 7.54 | |
Solid earnings growth is expected over the forecast horizon, complimented by a relatively attractive dividend yield. |
Buy/Sell Rationale:
Technical Analysis:
Long-term fundamental view:
Share Name and Position | MRP - BUY (Continue to hold) |
GRT - BUY (Continue to hold) |
ABG - Buy (Continue to hold) |
---|---|---|---|
Entry | 219.84 | 13.22 | 171.50 |
Current | 239.26 | 13.09 | 165.98 |
Movement | +8.8% | -1% | -3.2% |
The start of wave 5 in the Elliott wave price theory remains of interest. Remains just below its 200-day simple moving average. Fading downside momentum supports the trade strategy.
Our profit target is at R267 with a trailing stop-loss at R221. Exit the trade on 9 June 2025. |
The price is at one of the highest price bins out of the price distribution analysis remains of interest. Continues to test its 200-day simple moving average. Upside momentum supports the trade strategy.
Our profit target is at R16 with a trailing stop-loss at R12. Exit the trade on 17 November 2025. |
A favourable peer comparison for the share remains of interest. Remains just below its 200-day simple moving average. Fading downside momentum supports the trade strategy.
Our profit target is at R200 with a trailing stop-loss at R160. Exit the trade on 14 July 2025. |
FNB Stockbroking and Portfolio Management (Pty) Ltd, a subsidiary of FirstRand Bank Limited, an authorised Financial Services Provider and authorised user of the JSE limited (Reg no: 1996/011732/07). This Publication note is issued by FNB Stockbroking and Portfolio Management (Pty) Ltd for the information of clients only and should not be produced in whole or part without prior permission. Although FNB Stockbroking and Portfolio Management (Pty) Ltd is an Authorised Financial Services Provider, any opinions and/or analysis contained in this Publication are for informational purposes only and should not be considered advice, including but not limited to financial, legal or tax advice, or a recommendation to invest in any security or to adopt any investment strategy. The information contained herein has been obtained from sources/persons which we believe to be reliable but is not guaranteed for correctness, completeness or otherwise and we do not assume liability for loss arising from errors in the information or that may be suffered from using or relying on the information contained herein irrespective of whether there has been any negligence by us, our affiliates or any other employees of us, and whether such losses be direct or consequential. As market and economic conditions are subject to rapid change, any comments, opinions, and analysis is rendered as of the date of publishing and may change without notice. Such changes may have a material impact on the outcome of any investment. Securities involve a degree of risk and are volatile instruments. Past performance is not indicative of future performances. Securities or financial instruments mentioned in the Publication note may not be suitable for all investors and FNB Stockbroking and Portfolio Management (Pty) Ltd has bares no responsibility whatsoever arising from or as a consequence hereof. The material is not intended as a complete analysis of every material fact regarding any share, instrument, sector, region, market, country, investment, or strategy. The recipient of this Publication must make their own investment decision and is advised to contact his relationship manager for a personal financial analysis prior to making any investment decisions. Copyright 2018 by FNB Stockbroking and Portfolio Management (Pty) Ltd.